Telecommunication Technology-based Online Survey
Launched by TOMSK NATIONAL RESEARCH MEDICAL CENTER OF THE RUSSIAN ACADEMY OF SCIENCES · Nov 28, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into various health-related risk factors, especially those related to medications, such as how people take multiple drugs at once (polypharmacy), potential drug interactions, and self-medication practices, particularly in the context of COVID-19. The study uses an online survey to gather information from participants about their health, behaviors, and living conditions. By inviting people to participate through SMS messages, the researchers hope to better understand how these factors affect health across different regions of the country.
To be eligible for the trial, you need to be at least 18 years old and willing to complete the entire online questionnaire after giving your consent. If you join, you can expect to fill out the survey online, which is designed to be user-friendly and straightforward. This study aims to gather important information that could help improve safety and health outcomes related to medication use, so your participation could make a meaningful difference.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age of 18 years and older
- • signing the informed concent form online
- • completion of the entire questionnaire
- Exclusion Criteria:
- • age under 18 years
- • refuse to sign the informed concent form
About Tomsk National Research Medical Center Of The Russian Academy Of Sciences
The Tomsk National Research Medical Center of the Russian Academy of Sciences is a leading clinical research institution dedicated to advancing medical science and healthcare innovation. Committed to high standards of clinical excellence, the center integrates cutting-edge research with patient care, focusing on a diverse range of medical disciplines. With a robust infrastructure and a multidisciplinary team of experts, the center actively sponsors and conducts clinical trials aimed at improving diagnostic, therapeutic, and preventive strategies, ultimately contributing to the global body of medical knowledge and enhancing patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tomsk, , Russian Federation
Patients applied
Trial Officials
Nina D Anfinogenova, PhD
Principal Investigator
Tomsk NRMC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported